Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Clinical Validation Study of a Blood-Based cfDNA Methylation Assay for the Detection of Ovarian Cancer

NCT07593833 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT07593833
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07593833 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Clinical Validation Study of a Blood-Based cfDNA Methylation Assay for the Detection of Ovarian Cancer
Lead sponsor
Tongji Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
December 30, 2029
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early detection of cancer, ovarian cancer, ovarian neoplasms